Literature DB >> 30272334

MicroRNA‑433 inhibits cell growth and induces apoptosis in human cervical cancer through PI3K/AKT signaling by targeting FAK.

Jie Xu1, Weipei Zhu2, Lijuan Chen2, Lili Liu2.   

Abstract

The present study aimed to examine the role of microRNA‑433 in the growth and death of cervical cancer cells. RNA isolation, reverse transcription‑quantitative polymerase chain reaction analysis, an MTT assay, flow cytometry, and western blot analysis were used for this investigation. The results showed that the expression of microRNA‑433 was downregulated in patients with cervical cancer. The disease‑free survival and overall survival rates of patients with low expression levels of microRNA‑433 were lower, compared with those in patients with high expression levels of microRNA‑433. The expression levels of microRNA‑433 were downregulated in cervical cancer in vitro. It was found that the downregulation of microRNA‑433 promoted the growth and inhibited the apoptosis of cervical cancer cells through activating focal adhesion kinase (FAK)/phosphoinositide 3‑kinase (PI3K)/AKT signaling. However, the upregulation of microRNA‑433 induced apoptosis and suppressed the growth of cervical cancer cells through inhibiting the FAK/PI3K/AKT signaling pathway. In addition, FAK or PI3K inhibitors promoted the death of cervical cancer cells following the downregulation of microRNA‑433. These results revealed that microRNA‑433 suppressed the growth of cervical cancer cells via the FAK/PI3K/AKT signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30272334     DOI: 10.3892/or.2018.6718

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  4 in total

1.  The clinical value of miRNA-21 in cervical cancer: A comprehensive investigation based on microarray datasets.

Authors:  Zhi-Min Deng; Gan-Hong Chen; Fang-Fang Dai; Shi-Yi Liu; Dong-Yong Yang; An-Yu Bao; Yan-Xiang Cheng
Journal:  PLoS One       Date:  2022-04-29       Impact factor: 3.240

Review 2.  Role of PI3K/AKT pathway in squamous cell carcinoma with an especial focus on head and neck cancers.

Authors:  Soudeh Ghafouri-Fard; Ali Noie Alamdari; Yashar Noee Alamdari; Atefe Abak; Bashdar Mahmud Hussen; Mohammad Taheri; Elena Jamali
Journal:  Cancer Cell Int       Date:  2022-08-13       Impact factor: 6.429

3.  S100A16 Regulates HeLa Cell through the Phosphatidylinositol 3 Kinase (PI3K)/AKT Signaling Pathway.

Authors:  Haibin Zhang; Yongxiu Yang; Xueyao Ma; Wenhu Xin; Xuefen Fan
Journal:  Med Sci Monit       Date:  2020-01-02

Review 4.  Role of PI3K/AKT pathway in cancer: the framework of malignant behavior.

Authors:  Ningni Jiang; Qijie Dai; Xiaorui Su; Jianjiang Fu; Xuancheng Feng; Juan Peng
Journal:  Mol Biol Rep       Date:  2020-04-24       Impact factor: 2.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.